{
  "figure_1": "Vaccine effectiveness over time after the second COVID-19 vaccine dose in the cancer cohort versus the control population\nThe error bars represent 95% CIs.",
  "figure_2": "Heatmap showing overall vaccine effectiveness after the second dose and the interaction of patient age, sex, and cancer diagnosis\nGrey boxes denote insufficient data; white boxes denote inapplicable sections.",
  "figure_3": "Forest plot showing multivariable-corrected overall vaccine effectiveness among predefined cancer subgroups\nThe error bars represent 95% CIs. Regression models were fitted for the clinically relevant covariates of age, sex, Index of Multiple Deprivation, and ethnicity.",
  "figure_4": "Waterfall plot showing multivariable-corrected waning vaccine effectiveness at 3â€“6 months by key cancer subgroups\nThe most common solid tumours and haematological malignancies according to Cancer Research UK are shown."
}